Clin­i­cal kid­ney tri­als pos­i­tive

Western Suburbs Weekly - - Health -

HARRY Perkins In­sti­tute of Med­i­cal Re­search in Ned­lands re­cently an­nounced a break­through for chronic kid­ney dis­ease pa­tients fol­low­ing pos­i­tive clin­i­cal tri­als.

The treat­ment DMX-200 aims to con­trol ex­cess pro­tein in the urine (pro­tein­uria), a ma­jor symp­tom of the dis­ease.

With­out treat­ment, a pa­tient’s pro­tein­uria lev­els worsen, dam­ag­ing the kid­neys and lead­ing to fur­ther pro­tein leak­age – cre­at­ing a down­ward spi­ral of kid­ney func­tion.

Re­sults show 25 per cent of pa­tients ex­pe­ri­enced a 50 per cent re­duc­tion in pro­tein­uria, be­yond that achieved with cur­rent stan­dard of care ther­apy.

Re­searcher and chief sci­en­tific ad­vi­sor Kevin Pfleger said it could lead to bet­ter treat­ment op­tions.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.